• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Sunday, November 12, 2006 5:00 PM - 9:00 PM


An evening CME Symposium and Reception

A CME Symposium and Reception held
during the AAO 2006
Joint Meeting

Sunday, November 12, 2006
5:00 PM to 9:00 PM
The Venetian Resort Hotel Casino
Madame Tussaud's Wax Museum
3355 Las Vegas Blvd S
Las Vegas, Nevada


Program Chairman and Moderator

Richard K. Parrish II, MDProfessor, Department of Ophthalmology
Associate Dean for Graduate Medical Education

Bascom Palmer Eye Institute
University of Miami School of Medicine
Miami, Florida


Donald L. Budenz, MD, MPHProfessor of Ophthalmology, Epidemiology, and Public Health
Bascom Palmer Eye Institute
University of Miami School of Medicine
Miami, Florida

David S. Greenfield, MDProfessor of Ophthalmology
Bascom Palmer Eye Institute of the Palm Beaches
University of Miami School of Medicine
Palm Beach Gardens, Florida

Steven L. Mansberger, MD, MPHAdjunct Assistant Professor of Ophthalmology
Oregon Health Science University
Director, Glaucoma Service
Veteran's Hospital
Clinical Assistant Professor of Public Health and Preventive Medicine
Oregon Health Science University
Portland, Oregon

Felipe A. Medeiros, MDAssistant Professor of Ophthalmology
Hamilton Glaucoma Center
University of California, San Diego
La Jolla, California

Target Audience
This educational activity is intended for comprehensive ophthalmologists, glaucoma specialists, and resident ophthalmologists.

Statement of Need and Program Description
The ability to accurately diagnose glaucoma and identify patients at risk has evolved significantly in the past couple of years, providing physicians with improvements in managing the condition. High intraocular pressure (IOP) has been a standard diagnostic marker for primary open-angle glaucoma. However, we have seen that some patients with high IOP never progress to glaucoma, and some patients with low or normal IOP develop glaucoma. This has prompted interest in looking at structural causes for glaucoma thereby increasing the need for ophthalmologists to better understand and use tools and devices that evaluate the optic nerve. The ability to identify those patients at risk has advanced as well with learning from the field of cardiology. New tools have been developed that clinicians need to learn to incorporate into practice. This symposium will present experts' recommendations for the best diagnostic and risk assessment tools and how treatment and overall patient management can be improved.

Learning Objectives
Upon completion of this activity, participants should be able to:

Agenda5:00 PM–6:00 PM—Attendee Registration at The Venetian
6:00 PM–6:05 PM–Welcome and Introduction

6:05 PM–6:20 PM—How Do You Judge Risk, Learnings from EGPS
Steven L. Mansberger, MD, MPH

6:20 PM–6:35 PM—Diurnal and Long-term IOP Fluctuations
Felipe A. Medeiros, MD

6:35 PM–6:50 PM—Diagnosing Glaucoma Progression with Visual Fields
Donald L. Budenz, MD, MPH

6:50 PM–7:05 PM—OCT, GDX, HRT, and Judging Risk of Progression
David S. Greenfield, MD

7:05 PM–7:20 PM—The Meaning of Risk Assessment: Putting It All Together
Richard K. Parrish II, MD

7:20 PM–7:30 PM—Q&A Session

7:30 PM–9:00 PM—Reception at Madame Tussaud's Wax Museum

Accreditation Statement
This continuing medical education activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The New York Eye and Ear Infirmary and cme2, an independent subsidiary of Advanstar Communications Inc, publisher of Ophthalmology Times. The New York Eye and Ear Infirmary is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The New York Eye and Ear Infirmary designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy Statement
The New York Eye and Ear Infirmary requires that each participant/teacher in a CME-accredited educational activity disclose the existence of any financial interest and/or other relationship(s) (eg, paid speaker, employee, paid consultant on a board and/or committee for a commercial company) that would potentially affect the objectivity of his/her presentation. Speakers are also asked to make a disclosure that a product is still investigational when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity. The disclosed information in no way presumes to assess the participant's qualifications or suitability. The intention is to provide full disclosure of any potential conflict of interest, real or perceived, which is related to a specific event. Full disclosure of faculty and commercial relationships, if any, will be made at the program.

Provider Disclosure
The New York Eye and Ear Infirmary received a financial benefit from Pfizer Ophthalmics to administer this educational activity.

or call 888-248-0036
or 218-740-7130

Related Videos
Promising results for faricimab revealed in TENAYA, LUCERNE year 2 data
Orbis in-person training takes flight once again
Elkin: Talking about the importance of pediatric eye health and safety
Eye stroke: Mount Sinai program stresses awareness and emergent care for sudden vision loss
© 2024 MJH Life Sciences

All rights reserved.